Stem Cell Stock Review Updates Coverage On Accurexa

BEVERLY HILLS, CA / ACCESSWIRE / June 12, 2015 / The Stem Cell Stock Review has updated coverage on the company and will be providing ongoing coverage. Roland Rick Perry, Editor of the Review stated “Accurexa’s end goal is to provide a medical device that …

[Read the full article here]

Comments are closed.